Could Pfizer and Merck Be Big Winners With COVID Pills?

In this article:

Both Pfizer (NYSE: PFE) and Merck (NYSE: MRK) have recently announced they're advancing oral antiviral candidates targeting COVID-19 into late-stage testing. In this Motley Fool Live video recorded on Sept. 8, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss if the two drugmakers could be big winners with their COVID-19 pills.

Advertisement